These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22546235)

  • 1. Clinical practice in radioembolization of hepatic malignancies: a survey among interventional centers in Europe.
    Powerski MJ; Scheurig-Münkler C; Banzer J; Schnapauff D; Hamm B; Gebauer B
    Eur J Radiol; 2012 Jul; 81(7):e804-11. PubMed ID: 22546235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics.
    Salem R; Thurston KG
    J Vasc Interv Radiol; 2006 Sep; 17(9):1425-39. PubMed ID: 16990462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical vascular anatomy in the preparation of radioembolization.
    Paprottka PM; Jakobs TF; Reiser MF; Hoffmann RT
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):454-62. PubMed ID: 21567273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
    Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
    Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
    Jakobs TF; Hoffmann RT; Dehm K; Trumm C; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Helmberger TK; Reiser MF
    J Vasc Interv Radiol; 2008 Aug; 19(8):1187-95. PubMed ID: 18656012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arterial radioembolization of malignant liver tumors by yttrium-90 microspheres].
    Tarazov PG
    Vopr Onkol; 2013; 59(4):428-34. PubMed ID: 24032215
    [No Abstract]   [Full Text] [Related]  

  • 7. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
    Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 90Y Radioembolization after radiation exposure from peptide receptor radionuclide therapy.
    Ezziddin S; Meyer C; Kahancova S; Haslerud T; Willinek W; Wilhelm K; Biersack HJ; Ahmadzadehfar H
    J Nucl Med; 2012 Nov; 53(11):1663-9. PubMed ID: 22988059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comments on "Hepatic radioembolization with yttrium-90 glass microspheres for treatment of primary liver cancer" by Cao et al, Chin Med J 1999; 112: 430-432.
    Ho S; Lau WY; Leung WT
    Chin Med J (Engl); 2001 Apr; 114(4):433-4. PubMed ID: 11780473
    [No Abstract]   [Full Text] [Related]  

  • 10. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients.
    Bester L; Meteling B; Pocock N; Pavlakis N; Chua TC; Saxena A; Morris DL
    J Vasc Interv Radiol; 2012 Jan; 23(1):96-105. PubMed ID: 22079516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A first report of radioembolization for hepatic metastases from ocular melanoma.
    Kennedy AS; Nutting C; Jakobs T; Cianni R; Notarianni E; Ofer A; Beny A; Dezarn WA
    Cancer Invest; 2009 Jul; 27(6):682-90. PubMed ID: 19219675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction.
    Salem R; Thurston KG
    J Vasc Interv Radiol; 2006 Oct; 17(10):1571-93. PubMed ID: 17056999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical aspects of radioembolization with 90Y microspheres.
    Salem R; Lewandowski RJ; Sato KT; Atassi B; Ryu RK; Ibrahim S; Nemcek AA; Omary RA; Madoff DC; Murthy R
    Tech Vasc Interv Radiol; 2007 Mar; 10(1):12-29. PubMed ID: 17980315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
    Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A
    Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioembolization for the treatment of unresectable liver cancer: initial experience at a single center.
    Peynircioğlu B; Cil B; Bozkurt F; Aydemir E; Uğur O; Balkanci F
    Diagn Interv Radiol; 2010 Mar; 16(1):70-8. PubMed ID: 20180183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
    Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiologic findings following Y90 radioembolization for primary liver malignancies.
    Ibrahim SM; Nikolaidis P; Miller FH; Lewandowski RJ; Ryu RK; Sato KT; Senthilnathan S; Riaz A; Kulik L; Mulcahy MF; Omary RA; Salem R
    Abdom Imaging; 2009; 34(5):566-81. PubMed ID: 18777189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yttrium-90 resin microsphere radioembolization using an antireflux catheter: an alternative to traditional coil embolization for nontarget protection.
    Morshedi MM; Bauman M; Rose SC; Kikolski SG
    Cardiovasc Intervent Radiol; 2015 Apr; 38(2):381-8. PubMed ID: 24989143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating radioembolization ((90)Y microspheres) into current treatment options for liver tumors: introduction to the international working group report.
    Kennedy A; Coldwell D; Sangro B; Wasan H; Salem R
    Am J Clin Oncol; 2012 Feb; 35(1):81-90. PubMed ID: 20938320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.